In addition, TRAF2 was found to be strongly associated with immune cell infiltration in tumor microenvironment and efficacy of immunotherapy, with particular association with T cells, which was experimentally validated in hepatocellular carcinoma. This evidence concerns the gene TRAF2 and neoplasm.